HUE045679T2 - Valentonint tartalmazó transzdermális terápiai rendszer, és annak alkalmazása gyógyszerként - Google Patents

Valentonint tartalmazó transzdermális terápiai rendszer, és annak alkalmazása gyógyszerként

Info

Publication number
HUE045679T2
HUE045679T2 HUE16703289A HUE16703289A HUE045679T2 HU E045679 T2 HUE045679 T2 HU E045679T2 HU E16703289 A HUE16703289 A HU E16703289A HU E16703289 A HUE16703289 A HU E16703289A HU E045679 T2 HUE045679 T2 HU E045679T2
Authority
HU
Hungary
Prior art keywords
valentonin
medicament
system containing
therapeutic system
transdermal therapeutic
Prior art date
Application number
HUE16703289A
Other languages
English (en)
Hungarian (hu)
Inventor
Jean-Bernard Fourtillan
Marianne Fourtillan
Original Assignee
Soeur Josefa Menendez
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soeur Josefa Menendez filed Critical Soeur Josefa Menendez
Publication of HUE045679T2 publication Critical patent/HUE045679T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HUE16703289A 2015-02-04 2016-02-04 Valentonint tartalmazó transzdermális terápiai rendszer, és annak alkalmazása gyógyszerként HUE045679T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15305161 2015-02-04

Publications (1)

Publication Number Publication Date
HUE045679T2 true HUE045679T2 (hu) 2020-01-28

Family

ID=52573642

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE16703289A HUE045679T2 (hu) 2015-02-04 2016-02-04 Valentonint tartalmazó transzdermális terápiai rendszer, és annak alkalmazása gyógyszerként

Country Status (9)

Country Link
US (1) US10744122B2 (enExample)
EP (1) EP3253378B1 (enExample)
JP (1) JP6785779B2 (enExample)
KR (1) KR102361801B1 (enExample)
CN (1) CN107810003B (enExample)
CA (1) CA2975985A1 (enExample)
ES (1) ES2738633T3 (enExample)
HU (1) HUE045679T2 (enExample)
WO (1) WO2016124688A1 (enExample)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4134493A1 (de) * 1991-10-18 1993-04-22 Teves Gmbh Alfred Blockiergeschuetzte hydraulische bremsanlage
AU660336B2 (en) * 1991-10-18 1995-06-22 Alza Corporation Device for the transdermal administration of melatonin
FR2724384B1 (fr) 1994-09-14 1999-04-16 Cemaf Nouveaux derives de la 3,4-dihydro beta-carboline agonistes de la melatonine, leur procede de preparation et leur utilisation a titre de medicament
AU6595100A (en) * 1999-08-20 2001-03-19 Takeda Chemical Industries Ltd. Percutaneous absorption agents
IL155666A (en) * 2003-04-29 2013-12-31 Neurim Pharma 1991 Insomnia treatment
FR2898358B1 (fr) * 2006-03-08 2008-05-30 Macef Sa Association d'un antagoniste du recepteur 5ht2 et d'activateur du recepteur 5ht2 par modulation allosterique et leurs utilisations comme produits medicaux
FR2912405A1 (fr) * 2007-02-08 2008-08-15 Fourtillan Snc Derives des imidazo[1',5':1,6]pyrido[3,4-b]indoles et leur utilisation en therapeutique

Also Published As

Publication number Publication date
ES2738633T3 (es) 2020-01-24
JP2018507850A (ja) 2018-03-22
KR102361801B1 (ko) 2022-02-10
WO2016124688A1 (fr) 2016-08-11
EP3253378B1 (fr) 2019-05-08
US10744122B2 (en) 2020-08-18
CN107810003A (zh) 2018-03-16
EP3253378A1 (fr) 2017-12-13
JP6785779B2 (ja) 2020-11-18
CN107810003B (zh) 2022-05-03
KR20180004100A (ko) 2018-01-10
CA2975985A1 (fr) 2016-08-11
US20180000796A1 (en) 2018-01-04

Similar Documents

Publication Publication Date Title
IL253123B (en) Preparations for administration through the skin and their uses
SG10201912792YA (en) Therapeutic compounds and methods
GB201403093D0 (en) Therapeutic compounds and their use
IL254552A0 (en) Polycyclic carbamoylpyridone compounds and their pharmaceutical uses
IL249896B (en) New modulators for the glp-1 receptor and their use as drugs
GB201420039D0 (en) System for training a user in administering a medicament
GB201503961D0 (en) A transdermal drug administration device
ZA201802033B (en) Heteroaryl compounds and their use as therapeutic drugs
ZA201802256B (en) Compounds and therapeutic uses thereof
GB2538923B (en) A therapeutic agent for use in the treatment of infections
EP3263155A4 (en) Drug solution administering device
ZA201703976B (en) Dihydropyrimidine-2-one compounds and medicinal uses thereof
GB201617064D0 (en) Compounds and their therapeutic use
GB201502412D0 (en) Therapeutic use
IL248962A0 (en) Device and method for administering drugs to the brain
GB201406172D0 (en) Therapy and pharmaceutical composition
GB201418809D0 (en) Therapeutic agents and uses thereof
HUE045185T2 (hu) Új terápiás vegyület és terápiában történõ alkalmazása
GB201519644D0 (en) Therapy and pharmaceutical composition
SI3294253T1 (sl) Naprava za rekonstituiranje in apliciranje zdravil
GB201506786D0 (en) Therapeutic use
GB201410387D0 (en) Compounds and their therapeutic use
GB201403496D0 (en) Compounds and their therapeutic use
GB201502415D0 (en) New therapeutic use